| Line Item | 2026-02-27 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $343.0M | -0.0% | -6.2% |
| Cost of Revenue | $249.3M | +0.9% | -4.4% |
| Gross Profit | $93.7M | -2.5% | -10.5% |
| R&D Expense | $19.0M | +1.5% | -4.7% |
| SG&A Expense | $48.0M | -9.6% | -19.1% |
| Operating Income | $25.7M | +31.2% | +38.9% |
| Pre-tax Income | $53.0M | +573.7% | +220.6% |
| Income Tax | $14.4M | +698.3% | +88.5% |
| Net Income | $37.5M | +610.7% | +363.4% |
| EPS (Basic) | $0.59 | +1375.0% | +555.6% |
| EPS (Diluted) | $0.58 | +1350.0% | +544.4% |
| Line Item | 2026-02-27 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $489.2M | +6.0% | -21.3% |
| Inventory | $322.4M | +51.2% | +61.4% |
| Current Assets | $1.24B | +16.1% | -0.5% |
| Total Assets | $1.75B | +9.5% | -3.4% |
| Current Liabilities | $590.7M | +28.9% | +24.7% |
| Long-term Debt | $442.8M | -4.2% |
| Line Item | 2026-02-27 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $86.0M | +176.9% | — |
| Capital Expenditures | $4.5M | +56.2% | — |
| Investing Cash Flow | $26.9M | +897.0% | — |
| Financing Cash Flow | -$77.5M | -287.7% | — |
| Free Cash Flow | $81.6M | +189.1% | — |
| -32.8% |
| Total Liabilities | $1.14B | +14.6% | -5.0% |
| Stockholders' Equity | $394.8M | +1.3% | -34.5% |